No headlines found.
No press releases found.
No news found.
Langar Global HealthTech ETF (the "Fund") seeks long-term growth of capital. As an actively managed ETF, the Fund will not seek to replicate the performance of an index. The Fund intends to achieve its investment objective by investing a majority of its net assets in U.S. and foreign exchange-listed healthcare technology companies in the U.S and a number of developed countries around the world. Under normal circumstances, the Fund will invest at least 80% of the Fund's net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts ("ADRs") on those securities. These securities may be of any market capitalization.
Langar Global Healthtech ETF trades on the ARCA stock market under the symbol LGHT.
As of March 30, 2026, LGHT stock price declined to $8.51 with 9,138 million shares trading.
LGHT has a market cap of $3.41 million. This is considered a Sub-Micro Cap stock.
LGHT has underperformed the market in the last year with a return of -14.4%, while the SPY ETF gained +12.7%. In the last 3 month period, LGHT fell short of the market, returning -15.7%, while SPY returned -8.2%. However, in the most recent 2 weeks LGHT has outperformed the stock market by returning -3.8%, while SPY returned -4.3%.
LGHT support price is $8.37 and resistance is $8.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LGHT shares will trade within this expected range on the day.
